• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Covid-19: US approves emergency use of convalescent plasma despite warnings over lack of evidence.

作者信息

Mahase Elisabeth

机构信息

The BMJ.

出版信息

BMJ. 2020 Aug 25;370:m3327. doi: 10.1136/bmj.m3327.

DOI:10.1136/bmj.m3327
PMID:32843328
Abstract
摘要

相似文献

1
Covid-19: US approves emergency use of convalescent plasma despite warnings over lack of evidence.新冠疫情：尽管有缺乏证据的警告，美国仍批准恢复期血浆的紧急使用。
BMJ. 2020 Aug 25;370:m3327. doi: 10.1136/bmj.m3327.
2
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients.新冠疫情：美国食品药品监督管理局批准使用康复期血浆治疗重症患者。
BMJ. 2020 Mar 26;368:m1256. doi: 10.1136/bmj.m1256.
3
Covid-19: US FDA fires spokesperson over misleading claims about convalescent plasma.新冠疫情：美国食品药品监督管理局解雇就康复血浆发表误导性言论的发言人。
BMJ. 2020 Sep 2;370:m3400. doi: 10.1136/bmj.m3400.
4
Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.2014 - 2015年埃博拉疫情期间在几内亚进行的评估恢复期血浆治疗埃博拉病毒病的埃博拉治疗试验中的设计与分析考量
Clin Trials. 2016 Feb;13(1):13-21. doi: 10.1177/1740774515621056. Epub 2016 Jan 14.
5
Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.新冠疫情：尽管缺乏证据，美国仍紧急批准使用羟氯喹。
BMJ. 2020 Apr 1;369:m1335. doi: 10.1136/bmj.m1335.
6
Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.病原体灭活的埃博拉病毒康复期血浆：迈向制造标准化和质量控制的第一步，包括评估埃博拉特异性中和抗体。
Vox Sang. 2016 May;110(4):329-35. doi: 10.1111/vox.12376. Epub 2016 Jan 14.
7
Covid-19: UK regulator approves lateral flow test for home use despite accuracy concerns.新冠疫情：尽管存在准确性担忧，英国监管机构仍批准家用侧向流动检测。
BMJ. 2020 Dec 23;371:m4950. doi: 10.1136/bmj.m4950.
8
Covid-19: UK approves Pfizer and BioNTech vaccine with rollout due to start next week.新冠疫情：英国批准辉瑞和生物科技公司的疫苗，下周开始推广接种。
BMJ. 2020 Dec 2;371:m4714. doi: 10.1136/bmj.m4714.
9
Covid-19: UK approves Oxford vaccine as cases of new variant surge.新冠疫情：随着新变种病例激增，英国批准牛津大学研发的疫苗
BMJ. 2020 Dec 30;371:m4968. doi: 10.1136/bmj.m4968.
10
Covid-19: UK approves Moderna vaccine to be given as two doses 28 days apart.新冠疫情：英国批准Moderna疫苗分两剂接种，间隔28天。
BMJ. 2021 Jan 11;372:n74. doi: 10.1136/bmj.n74.

引用本文的文献

1
Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial.大规模、快节奏开展 COVID-19 临床试验：RECOVERY 试验经验。
Adv Biol Regul. 2022 Dec;86:100901. doi: 10.1016/j.jbior.2022.100901. Epub 2022 Jul 19.
2
Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK.在大流行期间提供新疗法，现行流程和规定是否适用？来自英国的 COVID-19 视角。
Pharmaceut Med. 2022 Oct;36(5):275-278. doi: 10.1007/s40290-022-00439-7. Epub 2022 Jul 28.
3
Making trials part of good clinical care: lessons from the RECOVERY trial.
将试验纳入优质临床护理：RECOVERY试验的经验教训。
Future Healthc J. 2021 Jul;8(2):e243-e250. doi: 10.7861/fhj.2021-0083.
4
Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?从新冠病毒临床试验中吸取的经验教训：我们是否应该改变临床试验方式？
Can J Cardiol. 2021 Sep;37(9):1353-1364. doi: 10.1016/j.cjca.2021.05.009. Epub 2021 May 30.
5
Reimagining the peer-review system for translational health science journals.重新构想转化健康科学期刊的同行评审系统。
Clin Transl Sci. 2021 Jul;14(4):1210-1221. doi: 10.1111/cts.13050. Epub 2021 May 7.
6
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
7
Predictive Analysis of the Neutralization Activity in Convalescent Plasmas From COVID-19 Recovered Patients in Zhejiang Province, China, January-March, 2020.2020年1月至3月中国浙江省新冠康复患者恢复期血浆中和活性的预测分析
Front Cell Infect Microbiol. 2021 Mar 16;11:650487. doi: 10.3389/fcimb.2021.650487. eCollection 2021.
8
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.用于治疗新型冠状病毒肺炎的恢复期血浆疗法：当前全球大流行中的观点与应用
Risk Manag Healthc Policy. 2020 Nov 23;13:2707-2728. doi: 10.2147/RMHP.S281388. eCollection 2020.
9
Treatment of immunocompromised COVID-19 patients with convalescent plasma.免疫抑制的 COVID-19 患者使用恢复期血浆治疗。
Transpl Infect Dis. 2021 Apr;23(2):e13477. doi: 10.1111/tid.13477. Epub 2020 Nov 29.